Down syndrome screening using first-trimester combined tests and contingent use of femur length at routine anomaly scan

Prenatal Diagnosis

Volumn 30, Issue 8, 2010, Pages 783-789

  Salomon, Laurent J ^a   Chevret, Sylvie ^b   Bussieres, Laurence ^c   Ville, Yves ^a   Rozenberg, Patrick ^c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

Contingent; Down syndrome; Femur length; First trimester; Screening; Soft markers; Trisomy 21

Indexed keywords

ADULT; ARTICLE; DOWN SYNDROME; ECHOGRAPHY; FALSE POSITIVE RESULT; FEMALE; FEMUR; FETUS RISK; FIRST TRIMESTER PREGNANCY; FRANCE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; PRENATAL SCREENING; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ADOLESCENT; ADULT; COHORT STUDIES; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; FEMUR; HUMANS; MIDDLE AGED; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL; YOUNG ADULT;

EID: 77955101817     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2550     Document Type: Article

References (53)

1. American College of Obstetricians and Gynecologists. 2007. Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 109: 217-227.
2. Bahado-Singh R, Shahabi S, Karaca M, Mahoney MJ, Cole L, Oz UA. 2002. The comprehensive midtrimester test: high-sensitivity Down syndrome test. Am J Obstet Gynecol 186: 803-808.
3. Benacerraf BR. 2000. Should sonographic screening for fetal Down syndrome be applied to low risk women? Ultrasound Obstet Gynecol 15: 451-455.
4. Benacerraf BR. 2005. The role of the second trimester genetic sonogram in screening for fetal Down syndrome. Semin Perinatol 29: 386-394.
5. Benacerraf BR, Barss VA, Laboda LA. 1985. A sonographic sign for the detection in the second trimester of the fetus with Down's syndrome. Am J Obstet Gynecol 151: 1078-1079.
6. Benacerraf BR, Gelman R, Frigoletto FD Jr 1987. Sonographic identification of second-trimester fetuses with Down's syndrome. N Engl J Med 317: 1371-1376.
7. Benn P, Wright D, Cuckle H. 2005. Practical strategies in contingent sequential screening for Down syndrome. Prenat Diagn 25: 645-652.
8. Benn PA, Fang M, Egan JF, Horne D, Collins R. 2003. Incorporation of inhibin-A in second-trimester screening for Down syndrome. Obstet Gynecol 101: 451-454.
9. Benn PA, Kaminsky LM, Ying J, Borgida AF, Egan JF. 2002. Combined second-trimester biochemical and ultrasound screening for Down syndrome. Obstet Gynecol 100: 1168-1176.
10. Bindra R, Heath V, Liao A, Spencer K, Nicolaides KH. 2002. One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies. Ultrasound Obstet Gynecol 20: 219-225.
11. Bishop AJ, Marteau TM, Armstrong D, et al. 2004. Women and health care professionals' preferences for Down's Syndrome screening tests: a conjoint analysis study. BJOG 111: 775-779.
12. Bromley B, Lieberman E, Shipp TD, Benacerraf BR. 2002. The genetic sonogram: a method of risk assessment for Down syndrome in the second trimester. J Ultrasound Med 21: 1087-1096; quiz 1097-1088.
13. Brumfield CG, Hauth JC, Cloud GA, Davis RO, Henson BV, Cosper P. 1989. Sonographic measurements and ratios in fetuses with Down syndrome. Obstet Gynecol 73: 644-646. (Pubitemid 19086979)
14. Cuckle H. 1996. Established markers in second trimester maternal serum. Early Hum Dev 47(Suppl): S27-29.
15. Cuckle H. 2000. Biochemical screening for Down syndrome. Eur J Obstet Gynecol Reprod Biol 92: 97-101.
16. Cuckle H, Benn P, Wright D. 2005. Down syndrome screening in the first and/or second trimester: model predicted performance using meta-analysis parameters. Semin Perinatol 29: 252-257.
17. Cuckle HS. 2002. Growing complexity in the choice of Down's syndrome screening policy. Ultrasound Obstet Gynecol 19: 323-326.
18. Devore GR. 2000. Trisomy 21: 91% detection rate using second-trimester ultrasound markers. Ultrasound Obstet Gynecol 16: 133-141.
19. Dicke JM, Gray DL, Songster GS, Crane JP. 1989. Fetal biometry as a screening tool for the detection of chromosomally abnormal pregnancies. Obstet Gynecol 74: 726-729.
20. Grandjean H, Sarramon MF. 1995. Femur/foot length ratio for detection of Down syndrome: results of a multicenter prospective study. The Association Francaise pour le Depistage et la Prevention des Handicaps de l'Enfant Study Group. Am J Obstet Gynecol 173: 16-19.
21. Grist TM, Fuller RW, Albiez KL, Bowie JD. 1990. Femur length in the US prediction of trisomy 21 and other chromosomal abnormalities. Radiology 174: 837-839.
22. Kagan KO, Valencia C, Livanos P, WRIGHT D, Nicolaides KH. 2009. Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11 + 0 to 13+ 6 weeks of gestation. Ultrasound Obstet Gynecol 33: 18-22.
23. Kornman LH, Wortelboer MJ, Beekhuis JR, Morssink LP, Mantingh A. 1997. Women's opinions and the implications of first-versus second-trimester screening for fetal Down's syndrome. Prenat Diagn 17: 1011-1018.
24. Lockwood C, Benacerraf B, Krinsky A, et al.1987. A sonographic screening method for Down syndrome. Am J Obstet Gynecol 157: 803-808.
25. Maiz N, Valencia C, Kagan KO, Wright D, Nicolaides KH. 2009. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 33: 512-517.
26. Malone FD, Canick JA, Ball RH, et al. 2005. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 353: 2001-2011.
27. Maymon R, Betser M, Dreazen E, Padoa A, Herman A. 2004. A model for disclosing the first trimester part of an integrated Down's syndrome screening test. Clin Genet 65: 113-119. (Pubitemid 38220111)
28. Muller F, Bussieres L. 1996. Maternal serum markers for fetal trisomy 21 screening. Eur J Obstet Gynecol Reprod Biol 65: 3-6.
29. Mulvey S, Wallace EM. 2000. Women's knowledge of and attitudes to first and second trimester screening for Down's syndrome. BJOG 107: 1302-1305.
30. Nicolaides KH. 2003. Screening for chromosomal defects. Ultrasound Obstet Gynecol 21: 313-321.
31. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O. 2005. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 25: 221-226.
32. Nyberg DA, Luthy DA, Resta RG, Nyberg BC, Williams MA. 1998. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases. Ultrasound Obstet Gynecol 12: 8-14.
33. Nyberg DA, Souter VL. 2001. Sonographic markers of fetal trisomies: second trimester. J Ultrasound Med 20: 655-674. (Pubitemid 32499950)
34. Palomaki GE, Steinort K, Knight GJ, Haddow JE. 2006. Comparing three screening strategies for combining first- and second-trimester Down syndrome markers. Obstet Gynecol 107: 367-375.
35. Perni SC, Chervenak FA, Kalish RB, et al. 2004. Intraobserver and interobserver reproducibility of fetal biometry. Ultrasound Obstet Gynecol 24: 654-658.
36. Peters MT, Lockwood CJ, Miller WA. 1989. The efficacy of fetal sonographic biometry in Down syndrome screening. Am J Obstet Gynecol 161: 297-300.
37. Platt LD, Medearis AL, Carlson DE, et al. 1992. Screening for Down syndrome with the femur length/biparietal diameter ratio: a new twist of the data. Am J Obstet Gynecol 167: 124-128.
38. Rozenberg P, Bussieres L, Chevret S, et al. 2006. Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population. Am J Obstet Gynecol 195: 1379-1387.
39. Salomon LJ, Bernard JP, Taupin P, Benard C, Ville Y. 2001. Relationship between nuchal translucency at 11-14 weeks and nuchal fold at 20-24 weeks of gestation. Ultrasound Obstet Gynecol 18: 636-637.
40. Salomon LJ, Ville Y. 2005. Quality control of prenatal ultrasound. Ultrasound Rev Obstet Gynecol 5: 297-303.
41. Schluter PJ, Pritchard G. 2005. Mid trimester sonographic findings for the prediction of Down syndrome in a sonographically screened population. Am J Obstet Gynecol 192: 10-16.
42. Senat MV, Bernard JP, Boulvain M, Ville Y. 2003. Intra- and interoperator variability in fetal nasal bone assessment at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 22: 138-141.
43. Snijders RJ, Sundberg K, Holzgreve W, Henry G, Nicolaides KH. 1999. Maternal age- and gestation-specific risk for trisomy 21. Ultrasound Obstet Gynecol 13: 167-170. (Pubitemid 29176889)
44. Spencer K. 1999. Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review. Br J Obstet Gynaecol 106: 1287-1293.
45. Spencer K, Spencer CE, Power M, Moakes A, Nicolaides KH. 2000. One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester. BJOG 107: 1271-1275.
46. Ville Y. 2008. 'Ceci n'est pas une echographie': a plea for quality assessment in prenatal ultrasound. Ultrasound Obstet Gynecol 31: 1-5.
47. Vintzileos AM, Egan JF. 1995. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography. Am J Obstet Gynecol 172: 837-844.
48. Wald NJ, Huttly WJ, Hackshaw AK. 2003a. Antenatal screening for Down's syndrome with the quadruple test. Lancet 361: 835-836.
49. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. 2003b. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study SURUSS. J Med Screen 10: 56-104. (Pubitemid 36734906)
50. Wapner R, Thom E, Simpson JL, et al. 2003. First-trimester screening for trisomies 21 and 18. N Engl J Med 349: 1405-1413.
51. Weisz B, Pandya PP, David AL, Huttly W, Jones P, Rodeck CH. 2007. Ultrasound findings after screening for Down syndrome using the integrated test. Obstet Gynecol 109: 1046-1052.
52. Winter TC, Uhrich SB, Souter VL, Nyberg DA 2000. The "genetic sonogram": comparison of the index scoring system with the age-adjusted US risk assessment. Radiology 215: 775-782.
53. Wright D, Bradbury I, Benn P, Cuckle H, Ritchie K. 2004. Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening. Prenat Diagn 24: 762-766.